In this article, Dr. Luis J. Montaner answers questions about how HIV works, the probability of finding a cure and what it’s like collaborating with local communities on HIV research. By Dr. Luis J.

Godfrey Dzhivhuho has dedicated his career to understanding HIV and other infectious diseases, inspired by the epidemic he witnessed growing up. Raised in Warrenton-Kimberly, South Africa, the oldest ...

Gilead Sciences' new shot is a drug named lenacapavir, which was tested in two studies and reportedly eliminated HIV infections in high-risk patients. People have to test negative for HIV before they ...

U.S. work combatting HIV/AIDS has saved millions of lives globally. Under the Trump administration, funding has been slow in ...

You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent clinical trial, received a CAR T cell for your cancer, or even just taken ...

Is a cure for HIV in sight? Since the virus that causes AIDS was identified over 40 years ago, finding a cure has been the holy grail of HIV research and the army of scientists conducting it. While ...

The Parkland Center for Clinical Innovation (PCCI) is using AI to tackle a persistent problem: HIV infections. PCCI's Vice President of Clinical and Social Health explains how it works. Editor’s Note: ...

A recent case of a man wrongly treated for HIV for seven years has raised concerns about testing accuracy. Experts explain how HIV tests work, why errors are rare, and what you should do if ...

The Food and Drug Administration approved a twice-yearly shot that prevented HIV infections in 99.9% of the people who received it in large clinical trials. The drug, developed by Gilead Sciences and ...